A provision tucked away in the massive draft government funding bill will strip away the ability of pharmacy benefit managers (PBMs) to offer employers in the private sector the flexibility to design pharmacy benefits that are unique to their business and their workers. In fact, the new government mandate could increase premiums and lead to pharmaceutical companies setting even higher prices for their drugs.
Here are five reasons the government should not intrude in private sector contracting between PBMs and employers:
